Heidi Calladine, OD
Optometrist · Warrenton, VANPI 1720154115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 42.7% of the total. Reporting peaked in 2022 at $282 and has fallen 86.6% since, to $38 in 2024. That places this record below the midpoint for optometrist clinicians in VA, where the typical reported total is $849.
Across 19 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$194
- Coopervision Inc.$61
- Alcon$52
- AbbVie$50
- Novartis$32
- Oasis Medical, Inc.$20
- plus $44 from 3 others
Across 21 payments — averaging $40.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$840
What the payments were for
- Food & beverage$454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 5 | $194 |
| Coopervision Inc. | 2 | $61 |
| Alcon | 3 | $52 |
| AbbVie | 3 | $50 |
| Novartis | 2 | $32 |
| Oasis Medical, Inc. | 1 | $20 |
| Notal Vision, Inc. | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$454 in reported general payments places this provider in the 35th percentile of 1,230 optometrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 67 | $1,097 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 15 | $463 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 18 | $361 |
| Prednisolone Acetate | 11 | $337 |
| Timolol Maleate | 18 | $218 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Warrenton
- Walter WhitleyNorfolk$546K
- Jacqueline TheisRichmond$80K
- Joseph AllenRichmond$75K
- Keith SmithsonReston$74K
- Michael SwattsChesapeake$59K
- Kurt DevitoVirginia Beach$54K
- Walter SchlabachHarrisonburg$31K
- Mark AbrahamFalls Church$30K
- David TangVirginia Beach$29K
- Tiffany LioneAldie$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.